Consumer medicine information

APO-Lansoprazole Capsules

Lansoprazole

BRAND INFORMATION

Brand name

APO-Lansoprazole

Active ingredient

Lansoprazole

Schedule

S4

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using APO-Lansoprazole Capsules.

What is in this leaflet

This leaflet answers some common questions about lansoprazole. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine. You may need to read it again.

What this medicine is used for

The name of your medicine is APO-Lansoprazole. It contains the active ingredient lansoprazole.

In adults it is used to treat:

  • reflux oesophagitis
  • peptic ulcers
  • Helicobacter pylori infection in patients with peptic ulcer or chronic gastritis
  • reflux-like and/or ulcer-like symptoms associated with acid-related dyspepsia

In children aged 1-17 years of age it is used to treat:

  • gastro-oesophageal reflux disease, including all grades of oesophagitis
  • erosive oesophagitis

Lansoprazole belongs to a group of medicines called proton pump inhibitors (PPIs). It works by decreasing the amount of acid the stomach makes, to give relief from excessive acid and allow healing to take place.

Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed this medicine for another reason.

There is no evidence that this medicine is addictive.

This medicine is available only with a doctor's prescription.

Before you take this medicine

When you must not take it

Do not take this medicine if you have allergy to:

  • lansoprazole or other proton pump inhibitors
  • any of the ingredients listed at the end of this leaflet

Some of the symptoms of an allergic reaction may include:

  • shortness of breath, cough, wheezing or difficulty breathing
  • swelling of the face, lips, tongue, throat or other parts of the body
  • rash, itching or hives on the skin

Do not take this medicine if you have severe liver disease.

Do not take this medicine if you are already taking atazanavir, a medicine used to treat HIV. Atazanavir is used to treat HIV infection. If it is taken at the same time as lansoprazole, it won't be absorbed properly and will be less effective in treating HIV infection.

Do not take this medicine after the expiry date printed on the pack or if the packaging is torn or shows signs of tampering. If it has expired or is damaged, return it to your pharmacist for disposal.

If you are not sure whether you should start taking this medicine, talk to your doctor.

Before you start to use it

Tell your doctor if you have allergies to any other medicines, foods, preservatives or dyes.

Tell your doctor if you have or have had any of the following medical conditions:

  • kidney or liver problems
  • inflammation of the bowel
  • a tumour in the stomach region
  • osteoporosis
  • low magnesium levels
  • fructose intolerance, glucose galactose malabsorption or sucrose-isomaltase insufficiency.

Do not take this medicine if you are pregnant or plan to become pregnant.

Do not take lansoprazole whilst pregnant until you and your doctor have discussed the risks and benefits involved.

It may affect your developing baby if you take it during pregnancy.

Do not take this medicine if you are breastfeeding or plan to breastfeed. Do not take lansoprazole whilst breastfeeding until you and your doctor have discussed the risks and benefits involved.

Taking other medicines

Tell your doctor or pharmacist if you are taking any other medicines, including any that you get without a prescription from your pharmacy, supermarket or health food shop.

Some medicines and lansoprazole may interfere with each other. These include:

  • theophylline, used to treat asthma
  • carbamazepine and phenytoin used to treat seizures (fits)
  • warfarin, used to prevent blood clots
  • oral contraceptives
  • sucralfate (used to treat stomach ulcers) and antacids (used to treat heartburn)

Lansoprazole should be taken at least an hour prior to taking sucralfate or an antacid.

  • ampicillin esters, used in some antibiotics
  • ketoconazole, used to treat fungal infections
  • iron preparations
  • digoxin, used to treat heart conditions
  • tacrolimus or mycophenolate used in transplant patients to reduce organ rejection
  • methotrexate, used in rheumatoid arthritis and some cancers to control immune response
  • atazanavir, nelfinavir and others that require an acidic pH to be effective to treat HIV
  • fluvoxamine, used to treat depression and anxiety

These medicines may be affected by lansoprazole or may affect how well it works. You may need different amounts of your medicines, or you may need to take different medicines.

Your doctor and pharmacist have more information on medicines to be careful with or avoid while taking lansoprazole.

How to take this medicine

Follow all directions given to you by your doctor or pharmacist carefully. Their instructions may be different to the information in this leaflet.

If you do not understand the instructions on the label, ask your doctor or pharmacist for help.

How much to take

Your doctor will tell you how much of this medicine you should take. This will depend on your condition and whether you are taking any other medicines.

Adults
The dose is usually 30 mg a day. The dose may vary from 15 mg to 30 mg a day depending on your condition.

Children (6 years or older)
For children between 6 to 11 years, the recommended dose depends on the weight of the child.

For children weighing 30 kg or less, the usual dose is 15 mg daily.

For children weighing over 30 kg, the usual dose is one 30 mg tablet daily.

For children between 12 to 17 years, the dose may vary from 15 mg to 30 mg a day depending on the condition.

How to take it

The capsule should be swallowed whole with plenty of water. Do not crush or chew.

If you have difficulty swallowing this medicine, the capsule can be opened and taken as follows:

  • Sprinkle the intact granules on one tablespoon of apple sauce, strained pears, cottage cheese or yoghurt and swallow immediately
  • or sprinkle the intact granules into a small volume of either apple juice, orange juice or tomato juice. Mix briefly and swallow immediately.
    To ensure complete delivery of the dose, the glass should be rinsed with two or more volumes of juice and the contents swallowed immediately.

Do not use other foods or liquids to swallow the granules because they have not been tested for use with this medicine.

If you have a nasogastric tube in place, this medicine may be given by a doctor or nurse by mixing the intact granules from the capsule with 40 mL of apple juice and injecting the mixture through the tube into the stomach. The tube is then flushed with more apple juice to clear it.

When to take it

Take this medicine in the morning before food.

Taking it at the same time each day will have the best effect. It will also help you remember when to take it.

How long to take it for

Continue taking your medicine for as long as your doctor tells you.

If you forget to take it

If it is almost time to take your next dose, skip the dose you missed and take your next dose when you are meant to.

Otherwise, take it as soon as you remember, and then go back to taking your medicine as you would normally.

Do not take a double dose to make up for the dose that you missed. This may increase the chance of you getting an unwanted side effect.

If you are not sure what to do, ask your doctor or pharmacist.

If you have trouble remembering to take your medicine, ask your pharmacist for some hints.

If you take too much (overdose)

Immediately telephone your doctor or the Poisons Information Centre (telephone 13 11 26) for advice or go to Accident and Emergency at the nearest hospital, if you think that you or anyone else may have taken too much of this medicine. Do this even if there are no signs of discomfort or poisoning. You may need urgent medical attention.

While you are taking this medicine

Things you must do

If you are about to be started on any new medicine, remind your doctor and pharmacist that you are taking this medicine.

Tell any other doctors, dentists, and pharmacists who treat you that you are taking this medicine.

If you are going to have surgery, tell the surgeon or anaesthetist that you are taking this medicine. It may affect other medicines used during surgery.

If you become pregnant or start to breastfeed while taking this medicine, tell your doctor immediately.

If you are about to have any blood tests, tell your doctor that you are taking this medicine. Lansoprazole may interfere with the results of some tests.

Keep all your doctor's appointments so that your progress can be checked. Your doctor may do some tests from time to time to make sure lansoprazole is working and to prevent unwanted side effects.

Things you must not do

Do not take this medicine to treat any other complaints unless your doctor tells you to.

Do not give your medicine to anyone else, even if they have the same condition as you.

Do not stop taking your medicine or lower the dosage without checking with your doctor. If you stop taking it suddenly, your condition may worsen, or you may have unwanted side effects.

Things to be careful of

Be careful when driving or operating machinery until you know how this medicine affects you.

Lansoprazole may cause dizziness in some people.

Side effects

Tell your doctor or pharmacist as soon as possible if you do not feel well while you are taking lansoprazole.

All medicines can have side effects. Sometimes they are serious, most of the time they are not. You may need medical attention if you get some of the side effects.

Do not be alarmed by the following lists of side effects. You may not experience any of them.

Ask your doctor or pharmacist to answer any questions you may have.

Tell your doctor if you notice any of the following:

Stomach or bowel problems such as:

  • diarrhoea, constipation
  • indigestion
  • nausea (feeling sick), vomiting
  • flatulence or wind
  • abdominal or stomach pain

Tell your doctor if you suffer from severe persistent diarrhoea and/or vomiting when taking lansoprazole.

As natural acid in the stomach helps to kill bacteria, the lowering of acid by acid-reducing medicines such as lansoprazole may cause some people to get certain stomach infections.

Difficulty in thinking or working due to:

  • headache
  • fatigue (tiredness)
  • dizziness
  • generally feeling unwell
  • joint or muscle aches or pain
  • feeling depressed, confused or having hallucinations

Changes to your appearance such as:

  • thinning hair
  • skin rashes
  • hives or itchy skin
  • breast enlargement and impotence in men (with long-term use)

Signs of infection such as:

  • cough, cold, sore throat or sinus
  • dry or sore mouth or throat
  • frequent and painful passing of urine

Changes in sight, hearing, taste or touch including:

  • taste disturbances
  • tingling or numbness of hands and feet
  • blurred vision
  • increased sensitivity to sunlight

Tell your doctor as soon as possible if you notice any of the following:

  • pain or indigestion
  • vomiting blood or food
  • passing black (blood-stained) motions

The above list includes serious side effects that may require medical attention.

If any of the following happen, tell your doctor immediately or go to Accident and Emergency at your nearest hospital:

  • pain in the kidney region
  • bruising or bleeding more easily than usual, bleeding under the skin or red or purple flat pinhead spots under the skin
  • severe blisters and bleeding in the lips, eyes, mouth, nose or genitals (Stevens-Johnson syndrome)
  • sudden or severe hives or itchy skin which may be accompanied by fever
  • frequent infections such as fever, severe chills, sore throat or mouth ulcers
  • watery or severe diarrhoea with stomach and bowel problems
  • yellowing of the skin or eyes, especially if accompanied by fever, fatigue, loss of appetite, dark coloured urine or light-coloured bowel movements
  • red, itchy blistering spots, especially if it appears in areas of the skin that are exposed to the sun and is accompanied by joint pain
  • swelling of the face, lips, tongue or throat, which may cause difficulty breathing
  • swelling of hands, ankles or feet
  • cramping of the muscles in your hands or feet
  • irregular heartbeat
  • fits or seizures
  • hallucinations.

These are very serious side effects and you may need urgent medical attention or hospitalisation.

Other side effects not listed above may occur in some patients.

Storage and disposal

Storage

Keep your medicine in its original pack until it is time to take them. If you take your medicine out of the original pack, they may not keep well.

Keep your medicine in a cool, dry place where the temperature will stay below 25°C.

Do not store this medicine or any other medicine in the bathroom or near a sink. Do not leave it on a window sill or in the car. Heat and dampness can destroy some medicines.

Keep it where children cannot reach it. A locked cupboard at least one and a half metres above the ground is a good place to store medicines.

Disposal

If your doctor tells you to stop taking this medicine or the expiry date has passed, ask your pharmacist what to do with any medicine that is left over.

Product description

What APO- Lansoprazole looks like

APO-Lansoprazole 15 mg
Yellow cap/yellow body, self-locked hard gelatin capsules of size '3' imprinted with 'L 15' on both cap and body, containing white to off-white pellets. AUST R 159350. AUST R 159346.

APO-Lansoprazole 30 mg
Purple cap/lavender body, self-locked hard gelatin capsules of size '1' imprinted with 'L 30' on both cap and body, containing white to off-white pellets. AUST R 159345. AUST R 159348

APO-Lansoprazole 15 mg and 30 mg are available in blister packs of 28 or 30 capsules.

Ingredients

Each APO-Lansoprazole Enteric Capsules contains 15 mg or 30 mg of lansoprazole as active ingredient.

It also contains the following inactive ingredients:

  • sucrose
  • maize starch
  • purified talc
  • hypromellose
  • titanium dioxide
  • methacrylic acid-ethyl acrylate copolymer (1:1)
  • macrogol 300
  • colloidal anhydrous silica
  • gelatin
  • Opacode S-1-277002 black

The 15 mg enteric capsule also contains the below colourants:

  • iron oxide yellow CI77492
  • quinoline yellow CI47005.

The 30 mg enteric capsule also contains the below colourants:

  • indigo carmine CI73015
  • carmoisine CI14720.

This medicine does not contain gluten and lactose. Contains sugars as sucrose. Contains sulfites.

Sponsor

Arrotex Pharmaceuticals Pty Ltd
15 – 17 Chapel Street
Cremorne VIC 3121
www.arrotex.com.au

This leaflet was last updated in:
September 2023.

Published by MIMS October 2023

BRAND INFORMATION

Brand name

APO-Lansoprazole

Active ingredient

Lansoprazole

Schedule

S4

 

1 Name of Medicine

Lansoprazole.

2 Qualitative and Quantitative Composition

Each APO-Lansoprazole enteric capsule contains enteric-coated delayed release pellets with 15 mg or 30 mg of lansoprazole.
Excipients with known effect. Contains sugars as sucrose. Contains sulfites.
For the full list of excipients, see Section 6.1 List of Excipients.

3 Pharmaceutical Form

APO-Lansoprazole 15 mg enteric capsules. Yellow cap/yellow body, self-locked hard gelatin capsules of size '3' imprinted with 'L 15' on both cap and body, containing white to off-white pellets.
APO-Lansoprazole 30 mg enteric capsules. Purple cap/lavender body, self-locked hard gelatin capsules of size '1' imprinted with 'L 30' on both cap and body, containing white to off-white pellets.

4 Clinical Particulars

4.9 Overdose

There is no information on the effect of acute overdosage. In a case of overdose, supportive and symptomatic therapy should be initiated. Doses of up to 180 mg/day for more than a year have been used to treat Zollinger-Ellison syndrome with no serious adverse effects.
For information on the management of overdose, contact the Poisons Information Centre on 131126 (Australia).

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. Negative results were obtained in gene mutation assays and in an in vivo assay of chromosomal damage. In vitro assays of chromosomal damage showed evidence of chromosomal aberrations, though this may reflect cytotoxicity rather than genotoxic activity.
Carcinogenicity. In a 2 year carcinogenicity study in rats, oral doses of 5, 15 or 50 mg/kg/day, 5 days per week, produced gastric ECL cell hyperplasia and carcinoid tumours in a dose related manner in both male and female rats. The incidence of these effects was markedly higher in female rats. A "no effect" dose was not established for female rats. An increased incidence of benign Leydig cell tumours and testicular hyperplasia was also reported at dose levels of 15 mg/kg/day. Two repeat 2 year carcinogenicity studies in rats using doses ranging from 5-150 mg/kg/day, 7 days per week confirmed these findings. The effects of lansoprazole on human male fertility have not been evaluated.
In mice, a 78 week carcinogenicity study was performed at doses of 1.5, 5, 15 and 50 mg/kg/day, 5 days per week. No gastric ECL cell carcinoids were seen. In a repeat carcinogenicity study, mice were dosed with 15, 75, 150 or 300 mg/kg/day, 7 days a week. Terminal studies showed ECL cell hyperplasia, mucosal hyperplasia/ hypertrophy and glandular dilatation and vacuolation at all dosages. Carcinoids were found in occasional animals receiving 15, 150 or 300 mg/kg/day.
Hypergastrinaemia secondary to prolonged hypochlorhydria has been postulated to be the mechanism by which ECL cell hyperplasia and gastric carcinoid tumours develop.
Juvenile animal studies. In an 8-week juvenile rat study, changes in male reproductive tissue (testes and epididymis) and heart (cardiac valve thickening) occurred at approximately 6-fold and 11-fold the expected human exposure, respectively, based on AUC (75-fold and 150-fold the expected human exposure based on body surface area). The findings reversed or trended towards reversibility after a 4-week drug-free recovery period. In a follow-up lansoprazole developmental sensitivity study, juvenile rats younger than postnatal Day 21 (age equivalent to approximately 2 years in humans) were more sensitive to the development of heart valve thickening, with valve thickening occurring at lower exposure (approximately 4-fold the expected human exposure based on AUC) in animals dosed starting at postnatal Day 14 (age equivalent to approximately 1 year in humans). The relevance of these findings to paediatric patients less than 12 years of age is unknown. The findings in this study are not relevant for patients 12 years of age and above.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

APO-Lansoprazole enteric capsules contain lansoprazole, which is a substituted benzimidazole. Lansoprazole is a white to slightly brownish crystalline, acid labile powder, slightly soluble in ethanol and almost insoluble in water (0.033 mg/mL), but more soluble at higher pH.
Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSLANSOP.gif Molecular formula: C16H14F3N3O2S.
Chemical name: 2 [[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulphinyl]-1H-benzimidazole.
Molecular weight: 369.36.
CAS number. 103577-45-3.

7 Medicine Schedule (Poisons Standard)

S4 - Prescription Only Medicine.

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/APOLANST.gif